vs

Side-by-side financial comparison of Target Hospitality Corp. (TH) and VERACYTE, INC. (VCYT). Click either name above to swap in a different company.

VERACYTE, INC. is the larger business by last-quarter revenue ($140.6M vs $73.5M, roughly 1.9× Target Hospitality Corp.). VERACYTE, INC. runs the higher net margin — 29.3% vs -20.3%, a 49.6% gap on every dollar of revenue. On growth, Target Hospitality Corp. posted the faster year-over-year revenue change (22.0% vs 18.5%). Over the past eight quarters, VERACYTE, INC.'s revenue compounded faster (20.5% CAGR vs 0.7%).

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

Veracyte Inc. is a leading molecular diagnostics company that develops and commercializes proprietary genomic testing solutions for early, accurate detection of cancer and other complex diseases. Its offerings help healthcare providers make better clinical decisions to improve patient outcomes, with core operations in the U.S. and expanding global market presence across key clinical segments.

TH vs VCYT — Head-to-Head

Bigger by revenue
VCYT
VCYT
1.9× larger
VCYT
$140.6M
$73.5M
TH
Growing faster (revenue YoY)
TH
TH
+3.4% gap
TH
22.0%
18.5%
VCYT
Higher net margin
VCYT
VCYT
49.6% more per $
VCYT
29.3%
-20.3%
TH
Faster 2-yr revenue CAGR
VCYT
VCYT
Annualised
VCYT
20.5%
0.7%
TH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TH
TH
VCYT
VCYT
Revenue
$73.5M
$140.6M
Net Profit
$-14.9M
$41.1M
Gross Margin
9.6%
72.5%
Operating Margin
-22.9%
26.4%
Net Margin
-20.3%
29.3%
Revenue YoY
22.0%
18.5%
Net Profit YoY
-219.1%
704.8%
EPS (diluted)
$-0.14
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TH
TH
VCYT
VCYT
Q4 25
$73.5M
$140.6M
Q3 25
$91.6M
$131.9M
Q2 25
$54.9M
$130.2M
Q1 25
$54.9M
$114.5M
Q4 24
$60.2M
$118.6M
Q3 24
$65.8M
$115.9M
Q2 24
$67.5M
$114.4M
Q1 24
$72.4M
$96.8M
Net Profit
TH
TH
VCYT
VCYT
Q4 25
$-14.9M
$41.1M
Q3 25
$-795.0K
$19.1M
Q2 25
$-14.9M
$-980.0K
Q1 25
$-6.5M
$7.0M
Q4 24
$12.5M
$5.1M
Q3 24
$20.0M
$15.2M
Q2 24
$18.4M
$5.7M
Q1 24
$20.4M
$-1.9M
Gross Margin
TH
TH
VCYT
VCYT
Q4 25
9.6%
72.5%
Q3 25
19.6%
69.2%
Q2 25
-0.6%
69.0%
Q1 25
32.7%
69.5%
Q4 24
61.5%
66.4%
Q3 24
68.7%
68.2%
Q2 24
69.4%
68.1%
Q1 24
67.8%
64.5%
Operating Margin
TH
TH
VCYT
VCYT
Q4 25
-22.9%
26.4%
Q3 25
0.1%
17.4%
Q2 25
-30.8%
-4.0%
Q1 25
-2.0%
2.5%
Q4 24
34.5%
3.5%
Q3 24
42.5%
10.4%
Q2 24
43.8%
4.0%
Q1 24
42.0%
-4.8%
Net Margin
TH
TH
VCYT
VCYT
Q4 25
-20.3%
29.3%
Q3 25
-0.9%
14.5%
Q2 25
-27.2%
-0.8%
Q1 25
-11.8%
6.2%
Q4 24
20.8%
4.3%
Q3 24
30.4%
13.1%
Q2 24
27.2%
5.0%
Q1 24
28.2%
-1.9%
EPS (diluted)
TH
TH
VCYT
VCYT
Q4 25
$-0.14
$0.50
Q3 25
$-0.01
$0.24
Q2 25
$-0.15
$-0.01
Q1 25
$-0.07
$0.09
Q4 24
$0.12
$0.07
Q3 24
$0.20
$0.19
Q2 24
$0.18
$0.07
Q1 24
$0.20
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TH
TH
VCYT
VCYT
Cash + ST InvestmentsLiquidity on hand
$8.3M
$362.6M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$389.3M
$1.3B
Total Assets
$530.2M
$1.4B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TH
TH
VCYT
VCYT
Q4 25
$8.3M
$362.6M
Q3 25
$30.4M
$315.6M
Q2 25
$19.2M
$219.5M
Q1 25
$34.5M
$186.1M
Q4 24
$190.7M
$239.1M
Q3 24
$177.7M
$274.1M
Q2 24
$154.3M
$235.9M
Q1 24
$124.3M
$209.2M
Total Debt
TH
TH
VCYT
VCYT
Q4 25
$1.7M
Q3 25
$2.0M
Q2 25
$26.3M
Q1 25
$42.9M
Q4 24
$1.5M
Q3 24
$994.0K
Q2 24
$1.1M
Q1 24
$179.9M
Stockholders' Equity
TH
TH
VCYT
VCYT
Q4 25
$389.3M
$1.3B
Q3 25
$402.4M
$1.3B
Q2 25
$401.3M
$1.2B
Q1 25
$415.3M
$1.2B
Q4 24
$421.1M
$1.2B
Q3 24
$417.6M
$1.2B
Q2 24
$397.2M
$1.1B
Q1 24
$375.5M
$1.1B
Total Assets
TH
TH
VCYT
VCYT
Q4 25
$530.2M
$1.4B
Q3 25
$541.2M
$1.4B
Q2 25
$533.7M
$1.3B
Q1 25
$562.5M
$1.3B
Q4 24
$725.8M
$1.3B
Q3 24
$709.8M
$1.3B
Q2 24
$697.0M
$1.2B
Q1 24
$687.2M
$1.2B
Debt / Equity
TH
TH
VCYT
VCYT
Q4 25
0.00×
Q3 25
0.01×
Q2 25
0.07×
Q1 25
0.10×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TH
TH
VCYT
VCYT
Operating Cash FlowLast quarter
$5.7M
$52.6M
Free Cash FlowOCF − Capex
$48.8M
FCF MarginFCF / Revenue
34.7%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
1.28×
TTM Free Cash FlowTrailing 4 quarters
$126.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TH
TH
VCYT
VCYT
Q4 25
$5.7M
$52.6M
Q3 25
$53.4M
$44.8M
Q2 25
$11.1M
$33.6M
Q1 25
$3.9M
$5.4M
Q4 24
$30.6M
$24.5M
Q3 24
$31.4M
$30.0M
Q2 24
$39.1M
$29.6M
Q1 24
$50.6M
$-9.0M
Free Cash Flow
TH
TH
VCYT
VCYT
Q4 25
$48.8M
Q3 25
$42.0M
Q2 25
$32.3M
Q1 25
$-11.6M
$3.5M
Q4 24
$20.4M
Q3 24
$27.7M
Q2 24
$26.8M
Q1 24
$-11.1M
FCF Margin
TH
TH
VCYT
VCYT
Q4 25
34.7%
Q3 25
31.8%
Q2 25
24.8%
Q1 25
-21.1%
3.1%
Q4 24
17.2%
Q3 24
23.9%
Q2 24
23.4%
Q1 24
-11.5%
Capex Intensity
TH
TH
VCYT
VCYT
Q4 25
2.7%
Q3 25
2.1%
Q2 25
1.0%
Q1 25
28.2%
1.6%
Q4 24
3.5%
Q3 24
1.9%
Q2 24
2.4%
Q1 24
2.2%
Cash Conversion
TH
TH
VCYT
VCYT
Q4 25
1.28×
Q3 25
2.34×
Q2 25
Q1 25
0.76×
Q4 24
2.44×
4.80×
Q3 24
1.57×
1.98×
Q2 24
2.13×
5.16×
Q1 24
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TH
TH

Services$40.9M56%
Hospitality And Facilities Services South$32.6M44%

VCYT
VCYT

Testing$135.8M97%
Products$3.8M3%
Biopharmaceutical And Other$686.0K0%

Related Comparisons